Actively Recruiting
Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion
Led by Peking University Third Hospital · Updated on 2020-09-18
200
Participants Needed
1
Research Sites
621 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective single-center study. Patients requiring posterior lumbar interbody fusion (PLIF) for degenerative disease are prospectively enrolled and followed. Patients enrolled in this study have asymptomatic pre-existing spinal canal stenosis at adjacent segment. This study will focus on the effects of preventative limited decompression at adjacent segment.
CONDITIONS
Official Title
Preventive Effect of Limited Decompression on Adjacent Segment Following Posterior Lumbar Interbody Fusion
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 80 years
- Diagnosed with lumbar spinal stenosis requiring surgery at L4-S1 levels
- Presence of asymptomatic pre-existing spinal canal stenosis (cerebrospinal fluid occlusion grade=1) at adjacent segment L3/4
- Failure of at least eight weeks of conservative treatment
You will not qualify if you...
- Unstable factors (slip, rotation, lateral bending) in adjacent segment L3/4
- Preoperative sagittal and coronal imbalance of the spine
- Lumbar infection or tumor
- Previous history of lumbar fusion surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Peking University Third Hospital
Beijing, Beijing Municipality, China, 100191
Actively Recruiting
Research Team
Z
Zhuo Ran Sun, Dr.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here